Related Experiment Videos
HDR intraluminal brachytherapy for lung tumours--a case report
Singapore Medical Journal
|June 1, 1994
Summary
Intraluminal brachytherapy effectively treated recurrent endobronchial metastasis from hypernephroma, relieving breathlessness without adverse effects. This palliative radiotherapy option shows promise for managing lung cancer symptoms.
Area of Science:
- Oncology
- Radiotherapy
- Pulmonary Medicine
Background:
- The lung is a frequent site for primary and metastatic tumors, causing symptoms like breathlessness and cough.
- Treatment for lung tumors is often palliative, aiming to alleviate symptoms and improve quality of life.
Observation:
- A case report details a patient with endobronchial metastasis from a primary hypernephroma.
- The metastasis recurred after external beam radiotherapy.
Findings:
- The patient received a single fraction of intraluminal brachytherapy (10Gy at 1 cm) using a High Dose Rate Ir192 Remote Afterloading Machine.
- No adverse effects were observed post-treatment.
Implications:
- Intraluminal brachytherapy provided symptomatic relief from breathlessness for 7 months.
- This technique offers a potential palliative treatment for recurrent endobronchial metastases.
- Further research may explore its role in managing advanced lung cancer symptoms.